LITHOSTAR MULTILINE

FDA Premarket Approval P870018 S019

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval for revision of the labeling regarding the risk of hypertension following renal lithotripsy (consistent with the conclusions of your final postapproval study report).

DeviceLITHOSTAR MULTILINE
Generic NameLithotriptor, Extracorporeal Shock-wave, Urological
ApplicantSIEMENS CORP.
Date Received1997-12-11
Decision Date1997-12-29
PMAP870018
SupplementS019
Product CodeLNS 
Advisory CommitteeGastroenterology/Urology
Supplement TypeSpecial (immediate Track)
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address SIEMENS CORP. 186 Wood Ave., South iselin, NJ 08830

Supplemental Filings

Supplement NumberDateSupplement Type
P870018Original Filing
S025 2000-07-10 Real-time Process
S024 2000-04-10 Real-time Process
S023 1999-02-12 Normal 180 Day Track
S022 1999-01-12 Real-time Process
S021 1998-05-01 Normal 180 Day Track
S020
S019 1997-12-11 Special (immediate Track)
S018
S017 1997-06-17 Normal 180 Day Track
S016 1996-05-20 Normal 180 Day Track
S015 1996-04-11 Normal 180 Day Track
S014 1996-03-13 Normal 180 Day Track
S013 1996-02-23 Normal 180 Day Track
S012
S011 1995-09-05 Normal 180 Day Track
S010 1995-05-08 Normal 180 Day Track
S009 1994-02-18 Normal 180 Day Track
S008 1994-02-07 Normal 180 Day Track
S007 1992-06-17 Normal 180 Day Track
S006 1992-01-29 Normal 180 Day Track
S005 1991-10-02 Normal 180 Day Track
S004 1990-12-07 Normal 180 Day Track
S003 1990-11-15 Normal 180 Day Track
S002 1989-04-12 Normal 180 Day Track
S001 1988-12-23 Normal 180 Day Track

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.